Home › Cancer (all types) › Hawaii › Honolulu
Cancer (all types) clinical trials in Honolulu, HI
13 studies for Cancer (all types) are looking for participants at sites in and around Honolulu (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
- Invision, LLC, Honolulu
- University of Hawaii Cancer Center, Honolulu
- Cardiology Associates, Inc, ‘Aiea · 7 mi away
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- The Queen's Medical Center - POB I, Honolulu
- The Queen's Medical Center - Punchbowl, Honolulu
- The Queen's Medical Center - Kuakini, Honolulu
- and 1 more
Connect for Cancer Prevention Study (Connect)
RecruitingObservational studyHealthy volunteers welcome
- Kaiser Permanente Hawaii, Honolulu
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- Hawaii Pacific Neuroscience, Honolulu
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
RecruitingObservational study
- Univercity of Hawaii Cancer Center, Honolulu
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Kapiolani Medical Center for Women and Children, Honolulu
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- and 10 more
EXoPERT EMERALD Clinical Study
RecruitingObservational studyHealthy volunteers welcome
- University of Hawaii Cancer Center, Honolulu
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 2/3
- Kaiser Permanente Moanalua Medical Center /ID# 275942, Honolulu
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
- Spark M. Matsunaga VA Medical Center, Honolulu
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
RecruitingHealthy volunteers welcome
- Univesity of Hawaii Cancer Center, Honolulu
GEMINI-NSCLC: NSCLC Biomarker Study
RecruitingObservational study
- Hawaii Cancer Care, Honolulu
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Durham, NC58 studies
- Washington, DC58 studies
- Chicago, IL51 studies
- Seattle, WA49 studies
- Atlanta, GA49 studies
- Arlington, VA48 studies
Other studies in Honolulu
- Obesity13 studies
- Breast Cancer12 studies
- Overweight11 studies
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Type 2 Diabetes7 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer7 studies
- Neuroblastoma6 studies
- Prostate Cancer5 studies
- Burkitt Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.